157 related articles for article (PubMed ID: 6224605)
1. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide.
Welsch CW; DeHoog JV; Moon RC
Carcinogenesis; 1983 Sep; 4(9):1185-7. PubMed ID: 6224605
[TBL] [Abstract][Full Text] [Related]
2. Lack of an effect of dietary retinoids in chemical carcinogenesis of the mouse mammary gland: inverse relationship between mammary tumor cell anaplasia and retinoid efficacy.
Welsch CW; DeHoog JV; Moon RC
Carcinogenesis; 1984 Oct; 5(10):1301-4. PubMed ID: 6237806
[TBL] [Abstract][Full Text] [Related]
3. Influence of chemopreventive agents on estradiol metabolism and mammary preneoplasia in the C3H mouse.
Osborne MP; Telang NT; Kaur S; Bradlow HL
Steroids; 1990 Mar; 55(3):114-9. PubMed ID: 2139751
[TBL] [Abstract][Full Text] [Related]
4. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
[TBL] [Abstract][Full Text] [Related]
5. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor.
Moon RC; Pritchard JF; Mehta RG; Nomides CT; Thomas CF; Dinger NM
Carcinogenesis; 1989 Sep; 10(9):1645-9. PubMed ID: 2527636
[TBL] [Abstract][Full Text] [Related]
6. Effect of N-(4-hydroxyphenyl) retinamide on food intake, growth, and mammary gland development in rats.
Radcliffe JD; Moon RC
Proc Soc Exp Biol Med; 1983 Nov; 174(2):270-5. PubMed ID: 6227008
[TBL] [Abstract][Full Text] [Related]
7. Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene.
Abou-Issa HM; Duruibe VA; Minton JP; Larroya S; Dwivedi C; Webb TE
Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4181-4. PubMed ID: 2967969
[TBL] [Abstract][Full Text] [Related]
8. Retinoid-tamoxifen interaction in mammary cancer chemoprevention.
McCormick DL; Moon RC
Carcinogenesis; 1986 Feb; 7(2):193-6. PubMed ID: 2936526
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2).
McCormick DL; Becci PJ; Moon RC
Carcinogenesis; 1982; 3(12):1473-6. PubMed ID: 6217919
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland in organ culture.
Mehta RG; Hultin TA; Moon RC
Biochem J; 1988 Dec; 256(2):579-84. PubMed ID: 2851995
[TBL] [Abstract][Full Text] [Related]
11. Effect of N-(4-hydroxyphenyl)retinamide on murine mammary tumor cells in culture.
Bunk MJ; Telang NT; Higgins PJ; Traganos F; Sarkar NH
Nutr Cancer; 1985; 7(1-2):105-15. PubMed ID: 2999720
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
Poliakov E; Samuel W; Duncan T; Gutierrez DB; Mata NL; Redmond TM
PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568
[TBL] [Abstract][Full Text] [Related]
13. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
Silverman J; Katayama S; Radok P; Levenstein MJ; Weisburger JH
Nutr Cancer; 1983; 4(3):186-91. PubMed ID: 6221232
[TBL] [Abstract][Full Text] [Related]
14. Distribution and metabolism of the retinoid, N-(4-methoxyphenyl)-all-trans-retinamide, the major metabolite of N-(4-hydroxyphenyl)-all-trans-retinamide, in female mice.
Hultin TA; Filla MS; McCormick DL
Drug Metab Dispos; 1990; 18(2):175-9. PubMed ID: 1971569
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.
Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970
[TBL] [Abstract][Full Text] [Related]
17. Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice.
Hultin TA; McCormick DL; May CM; Moon RC
Drug Metab Dispos; 1988; 16(6):783-8. PubMed ID: 2907453
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of rat mammary carcinogenesis by an arotinoid without a polar end group (Ro 15-0778).
Bollag W; Hartmann HR
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):131-5. PubMed ID: 2965015
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats.
Ratko TA; Detrisac CJ; Dinger NM; Thomas CF; Kelloff GJ; Moon RC
Cancer Res; 1989 Aug; 49(16):4472-6. PubMed ID: 2525951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
